The medication was designed to help lower LDL-C levels with just two doses per year. 

The new analysis focused on nearly 5 million individuals who received either the Moderna or Pfizer/BioNTech vaccine.

Researchers tracked data from more than 600,000 patient deaths in the United States, sharing their findings in the Journal of the American Heart Association. 

The study included cardiac MRI scans of nearly 30,000 patients. 

A new meta-analysis compared outcomes associated with the two popular DOACs. 

We need to make the future instead of waiting for it to happen.

The direct oral anticoagulant is now approved for 11 different indications. 

The Philips CavaClear Laser Sheath earned the agency’s breakthrough device designation back in July.

This latest analysis tracked more than 300 patients for a median follow-up period of nearly five years.

Paxlovid becomes the first treatment for the coronavirus taken in pill form, the federal agency announced.